Latest Breaking News On - தலைமை தகவல்தொடர்புகள் - Page 11 : comparemela.com
Washington Women In Public Relations Announces 2021 Emerging Leaders Awards Winners
prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.
Communications & External Relations Overview
eastwestcenter.org - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from eastwestcenter.org Daily Mail and Mail on Sunday newspapers.
CEO Liselott Johansson appoints new management team for Greater Than
STOCKHOLM, May 19, 2021 /PRNewswire/
Greater Than (GREAT) the Insurtech using AI to predicting motor risk in real-time per individual driver now appoints new management group consists of a combination of former Greater Than employees and a couple of recruits. It provides continuity while adding new skills to the organization.
New recruitments are Markus Waldenström named CFO. Markus most recently comes from Telia Ventures. Helena Norrthon is recruited as General Counsel. Before joining Greater Than, Helena was serving as General Counsel at SIS. New to the team is also Lars Jatko who is appointed as Head of Product Development for the company, effective May 17, 2021. Lars comes most recently from a long-term assignment at Nasdaq.
Share this article
Uliledlimab is a highly differentiated CD73 antibody with a unique epitope that confers pharmacological advantages
Data from U.S. phase 1 dose escalation trial demonstrates favorable safety and tolerability with no dose-limiting toxicities; preliminary clinical activity of uliledlimab has been observed in patients with advanced cancers
ASCO abstract among Top 12 selected for poster discussion
I-Mab to host call for investors on June 7, 2021 at 8 am ET
SHANGHAI and GAITHERSBURG, Md., May 19, 2021 /PRNewswire/ I-Mab (the Company ) (Nasdaq: IMAB), a clinical stage biopharmaceutical company committed to the discovery, development and commercialization of novel biologics, today announced that an abstract detailing clinical data from its U.S. phase 1 study of uliledlimab in combination with atezolizumab (TECENTRIQ®) in patients with advanced cancer will be presented at the 2021 American Society of Clinical Oncology (ASCO) Annual Meeting, taking place June 4-8, 2
vimarsana © 2020. All Rights Reserved.